Fresenius’ Performance on Track as Uncertain Akorn Investigation Is a Potential Positive
We don’t anticipate a change to our fair value estimate or narrow moat rating for Fresenius, as the company’s fourth-quarter performance continues to mostly track our expectations. The quarter includes a number of nonrecurring items, including a reserve charge for the Foreign Corrupt Practices Act investigation at Fresenius Medical Care and a gain from recent tax legislation in the U.S. While we plan to make a few adjustments to our model and the timing of the NxStage acquisition could affect ou...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.